UCLA stented patients | WASID warfarin group | WASID aspirin group | p Value (χ2 test) | |
African–American (%) | 0 | 31.5 | 29.6 | p<0.001 |
White (%) | 52* | 58.5 | 57.9 | p=0.831 |
Other race (%) | 48* | 10 | 12.5 | p<0.001 |
Female (%) | 27 | 37 | 40 | p=0.876 |
Hypertension (%) | 90 | 86.1 | 82.1 | p=0.537 |
Diabetes (%) | 53 | 39.8 | 36.2 | p=0.197 |
Dyslipidemia (%) | 85 | 73.0 | 68.6 | p=0.142 |
Mean age (years) | 65 | 64.3 | 62.8 | |
Time from qualifying event to treatment (days) | 14 (median) | 16 | 18 | |
No with 50–70% stenosis (%) | 12 | 49.8 | 50 | p<0.001 |
No with 70–99% stenosis (%) | 88 | 36.8 | 37.3 | p<0.001 |
Stenosis | ||||
Carotid (%) | 37 | 22.9 | 20.3 | p=0.148 |
Middle cerebral (%) | 14 | 31.1 | 33.9 | p=0.089 |
Vertebral (%) | 23 | 19.3 | 19.6 | p=0.925 |
Basilar (%) | 23 | 20.4 | 20.3 | p=0.980 |
Multiple stenoses (%) | 2 | 6.4 | 5.9 | p=0.589 |
↵* Race could not be identified in 14 patients so data were available for a total of 41, 14 and 27 patients, respectively.